Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
13 December, 2018 04:29 IST
State Bank of India reduces retail loan rates by 5 bps
Source: IRIS | 02 Nov, 2017, 10.07AM
Comments  |  Post Comment

State Bank of India (SBI), the largest public sector bank in India has taken another leap to give further boost to the retail loan by reducing home loan and auto loan by 5 bps. The bank has reduced Home Loans interest rates by 05 basis points to 8.30% per annum. Similarly, Auto loan is now offered at a starting interest rate of 8.70% per annum compared to earlier from 8.75%. With this reduction, SBI's offering in home loan is the lowest in the market. The new rates will be effective from November 01, 2017.

P K Gupta, MD, Retail and Digital Banking, (Q,N,C,F)* SBI said ''SBI has always been at the forefront in the passing the benefit to the customers. With this reduction in rates, we are offering lowest rates for most of our product offering in the retail loans. Lower rates along with wide distribution network & use of digital technology to enhance customer experience is a perfect package for any retail loan customer.''

The effective interest rate for all eligible salaried customers will be 8.30% per annum for loans upto Rs. 30 lacs. Rates have been reduced by 5 bps point in all the brackets. Over and above of 8.30% rate, an eligible home loan customer can also avail of an interest subsidy of Rs. 2.67 lacs under the Pradhan Mantri Awas Yojana scheme. 

For car loan customer, the loan amount ranges from 8.70% per annum to 9.20% per annum compared to earlier range of 8.75% to 9.25% PA. The exact rate depends on the amount of loan and the credit score of the individual.

Shares of the company declined Rs 3.9, or 1.22%, to trade at Rs 315.90. The total volume of shares traded was 242,910 at the BSE (9.59 a.m., Thursday).

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Ashok Leyland signs defence agreement with ELBIT Systems - 12-Dec-2018 09:41
Wipro launches automotive innovation center in Michigan - 12-Dec-2018 09:37
Liva Pharmaceuticals gets USFDA approval for its sANDA - Ranitidine Injection - 12-Dec-2018 09:35
Dr Reddy's Labs launches Omeprazole tablets in US market - 12-Dec-2018 09:31
Strides Vivimed JV receives consent for Albendazole tablets - 12-Dec-2018 09:27
Unichem Lab gets tentative nod for Tadalafil tablets - 12-Dec-2018 09:25
Zydus Wellness gets CCI approval for acquisition of Heinz India - 12-Dec-2018 09:20
Wipro Digital to expand Asia Pacific design capabilities in Australia - 11-Dec-2018 09:26
Wipro Digital to expand Asia Pacific design capabilities in Australia - 11-Dec-2018 09:24
Lupin receives tentative USFDA approval for Apixaban tablets - 11-Dec-2018 09:20
Lupin receives EIR from USFDA for Indore facility - 10-Dec-2018 16:10
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer